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DDifferential branch pulmonary artery growth after the Norwood
procedure with right ventricle–pulmonary artery conduit versus
modified Blalock–Taussig shunt in hypoplastic left heart syndrome
Jay D. Pruetz, MD,a Sarah Badran, MD,a Fred Dorey, PhD,b Vaughn A. Starnes, MD,c and Alan B. Lewis, MDa
Objectives: The Norwood procedure with right ventricle–pulmonary artery conduit is thought to improve post-
operative hemodynamics in hypoplastic left heart syndrome, but its effects on pulmonary artery growth are
unknown. This study evaluated pulmonary artery growth after the Norwood procedure in patients with a right
ventricle–pulmonary artery conduit as compared with patients with a modified Blalock–Taussig shunt.
Methods: A total of 159 patients at our institution underwent the Norwood procedure between January 2000 and
September 2005. Patients were divided into group A or B if they had a modified Blalock–Taussig shunt (n¼ 103)
or a right ventricle–pulmonary artery conduit (n ¼ 56). Angiograms from the pre-Glenn catheterizations were
used to measure pulmonary artery size and assess shunt stenosis (n ¼ 64).
Results: Fifty-five (53.4%) patients in group A versus 40 (71.4%) in group B underwent Glenn surgery. Group B
patients often required an additional shunt (modified Blalock–Taussig) before the Glenn procedure because of
hypoxemia (8/40 vs 1/55; P ¼ .004). Branch pulmonary artery growth was better in group B patients who did
not require an additional shunt (Nakata index 212 vs 169 mm2/m2; P ¼ .004) and more balanced than in group
A (right pulmonary artery/left pulmonary artery ratio ¼ 1.02 vs 1.39; P ¼ .001) as a result of greater left pulmo-
nary artery size (29 vs 19 mm2; P¼ .001). However, group B experienced more shunt stenosis (8/32 vs 2/32; P¼
.001), underwent the Glenn operation earlier (192 vs 246 days; P ¼ .03), and had central pulmonary artery
hypoplasia develop more often than group A patients (25/32 vs 14/32; P ¼ .01).
Conclusion: The Norwood procedure with a right ventricle–pulmonary artery conduit promotes better distal left
pulmonary artery growth resulting in more balanced branch pulmonary artery size, but central pulmonary artery
hypoplasia occurs more often. Early right ventricle–pulmonary artery conduit stenosis also increases the need for
additional shunting or early Glenn surgery.
Congenital Heart Disease Pruetz et alHypoplastic left heart syndrome (HLHS) is a relatively
uncommon form of congenital heart disease (CHD),
accounting for less than 2% of all CHD, yet it accounts
for the highest mortality among infants with CHD (15/
100,000).1 The most successful palliation for this complex
form of CHD has been the Norwood procedure (NP), first
introduced in 1983 and still the primary operation for
HLHS.2 The NP has undergone several modifications over
the years, but perhaps none as controversial as the right ven-
tricle–pulmonary artery (RV–PA) conduit used in place of
a modified Blalock–Taussig shunt (mBTS).3,4 Since its
emergence there has been much debate over the benefits of
the RV–PA conduit. The main advantage anticipated with
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pulmonary vascular bed resulting in higher systemic dia-
stolic pressure and improved coronary blood flow.5-8 The
physiology with the RV–PA conduit is believed to provide
more stable immediate postoperative hemodynamics and
reduced intermediate stage mortality.9-12 Another benefit
proposed with the RV–PA conduit is greater flow pulsatility
in the pulmonary artery (PA) promoting better PA growth
over time.13 As a result, these patients might require less
additional surgery to augment or repair their PAs at the sub-
sequent stages of single ventricle palliation.14,15 Some
reported disadvantages of the RV–PA conduit include
increased incidence of shunt stenosis.16-18 This study sought
to evaluate the differences in PA growth and PA surgical
interventions after the stage I NP with the RV–PA conduit
versus the mBTS to help guide future surgical decision-mak-
ing for infants with HLHS.
METHODS
A retrospective review of the surgical database at our institution identi-
fied 159 patients who underwent stage I NP between January 2000 and
September 2005. Patients presenting after September 2005 were enrolled
in the single ventricle trial sponsored by the Pediatric Heart Network and
were not included in the current series. Before initiation of the study the
Committee on Clinical Investigations (institutional research board)
approved the research protocol. Enrolled patients had severe obstruction
to left ventricular (LV) outflow, hypoplasia of the LV, and a singlergery c June 2009
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DAbbreviations and Acronyms
CHD ¼ congenital heart disease
HLHS ¼ hypoplastic left heart syndrome
LV ¼ left ventricle (ventricular)
mBTS ¼ modified Blalock–Taussig shunt
NP ¼ Norwood procedure
PA ¼ pulmonary artery
PTFE ¼ polytetrafluoroethylene
RV ¼ right ventricle (ventricular)
RV–PA ¼ right ventricle–pulmonary artery
morphologically right ventricle (RV) as the systemic pumping chamber.
Patients were divided into either group A or group B on the basis of whether
an mBTS or an RV–PA conduit was placed at the time of the stage I NP. The
RV–PA conduit was first performed at our institution in September 2002;
before that date the mBTS was the shunt of choice and after that date the
choice of shunt was at the discretion of the surgeon. The primary study pop-
ulation comprised the total number of patients with pre-Glenn cardiac cath-
eterization data available for analysis at our institution (n ¼ 64, 32 in each
group). Patients who initially had an RV–PA conduit placed and subse-
quently required an additional shunt were analyzed within group B in accor-
dance with an intention to treat protocol. Subgroup analysis was also
performed for patients with an RV–PA conduit who had no additional shunt
placed. Figure 1 displays a flow chart of outcomes for the entire study
population. Patients who had their pre-Glenn diagnostic catheterizations
performed at other institutions were included in mortality analysis only,
but excluded from the primary study group (n ¼ 36). Preoperative demo-
graphics, risk factors, and surgical data were compared for our primary
study population. Surgical morbidity and mortality data through completion
of the Glenn procedure were collected for all patients not lost to follow-up.Surgical Procedure
The stage I NP for each patient was performed by the same surgeon
(V.A.S.) and consisted of atrial septectomy followed by aortic arch recon-
struction using the main PA, native ascending aorta, and pulmonary homo-
graft patch with the patient under deep hypothermic circulatory arrest. The
PA bifurcation was patched with a polytetrafluoroethylene (PTFE) patch
(Gore-Tex patch; W. L Gore & Associates, Inc, Flagstaff, Ariz) after
removal of the main PA. The final step involved the placement of either
an mBTS using a PTFE tube (Gore-Tex tube) from the innominate artery
to the right PA or placement of a PTFE conduit from the RV infundibulum
just below the pulmonary valve to the central PA at the bifurcation (RV–PA
conduit). The RV–PA conduit was typically placed to the left of the neoaorta
(>95% of patients) and anastomosed directly to the PTFE patch on the PA
bifurcation, whereas the mBTS was anastomosed directly to the right PA.
No valved RV–PA conduits were used.
Angiographic Analysis
Pre-Glenn cardiac catheterizations performed at our institution were
reviewed (n¼ 32 in each group) with subgroup analysis of group B patients
with only an RV–PA conduit (n ¼ 26). A single cardiologist (J.D.P.)
reviewed all angiograms and performed off-line measurements of the PAs
that were agreed on with a second observer (A.B.L.). The diameters of
the right and left PAs were measured just proximal to the origin of the
first-order PA branches (Figure 2) and used to calculate a Nakata index
(combined right PA and left PA cross-sectional area indexed to body surface
area).19 A ratio of right PA to left PA cross-sectional area was used for com-
parison of differential PA growth. All PA measurements were corrected on
the QuantCore system (Siemens Medical Solutions, Malvern, Pa) and cali-
brated to known catheter diameter. Shunt stenosis was defined as greater
than 50% narrowing of the shunt diameter and was correlated with intrao-
perative findings at time of surgery. Shunt-related PA stenosis was defined
as greater than 50% narrowing of the PA diameter at the shunt insertion site
compared with the adjacent PA diameter. Central PA hypoplasia was de-
fined as narrowing of the central PA to greater than 50% of the combined
average of right PA and left PA cross-sectional area.FIGURE 1. Flow chart of outcomes after the stage I NP with mBTS (group A) compared with RV–PA (group B) between January 2000 and September 2005.
These data are expressed as total number of patients (% of total study group). The lowest row of boxes denotes the primary study group (n¼ 32 in each group).
Cath, Catheterization; LTF, lost to follow-up; mBTS, modified Blalock–Taussig shunt; NP, Norwood procedure; RV–PA, right ventricle–pulmonary artery
conduit.
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DFIGURE 2. Angiograms performed at the pre-Glenn cardiac catheterization in a patient after stage I NP with mBTS (A) and RV–PA (B). Individual branch
PA diameters were measured just before the takeoff of the upper lobe branch (white arrows). Note the central PA hypoplasia and shunt-related PA stenosis in
panel B for the patient with RV–PA NP. mBTS, Modified Blalock–Taussig shunt; NP, Norwood procedure; PA, pulmonary artery; RV–PA, right ventricle–
pulmonary artery conduit.Statistical Methods
Data were evaluated with standard statistical software (Stata SE version
10; Stata Corporation, College Station, Tex). Continuous variables are
expressed as mean  standard deviation or median (range). Comparative
univariate analyses were performed by the t test, Mann–Whitney U test,
or Wilcoxon signed rank test, as appropriate. The c2 test or 2-sided Fisher’s
exact test were used for ordinal and binomial data. Kaplan–Meier survival
analysis was used to compare survival with that of the Glenn operation
for both procedures with the competing risks of death as well as time to re-
intervention with an additional shunt if required before the Glenn operation.
RESULTS
No significant differences were seen between the two
groups for demographic data or preoperative risk factors at
the time of stage I NP (Table 1). Also, no difference was
observed for the presence of aortic atresia versus aortic
stenosis (group A 21/32 vs group B 28/32; P¼ .077). Group
A included 1 patient with Turner syndrome and 1 with asple-
nia syndrome. Group B included a patient with CHARGE
association.* A notable surgical difference between the
groups was the larger diameter of the RV–PA conduit com-
pared with the mBTS (5.3 vs 3.6 mm; P<.001). All patients
were placed on an aspirin regimen postoperatively except for
1 patient in the RV–PA group owing to hypersensitivity
reaction. Analysis of the entire study population revealed 8
patients in group B and 1 in group A who required an addi-
tional shunt before the Glenn operation (8/40 vs 1/55; P ¼
.004). A Kaplan–Meier analysis to evaluate time to reinter-
vention before the Glenn operation for the two groups
showed a higher rate of additional shunt placement in the
patients receiving an RV–PA conduit (Figure 3). This
involved the placement of an additional mBTS in all cases.
Pre-Glenn catheterization data for the primary study group
showed no significant differences for age, weight, pulmo-
nary flow, systemic flow, pulmonary/systemic flow ratio,
* CHARGE ¼ coloboma, heart disease, atresia choanae, retarded growth and retarded
development and/or central nervous system anomalies, genital hypoplasia, and ear
anomalies and/or deafness.1344 The Journal of Thoracic and Cardiovascular Suor hemoglobin (Table 2). The RV–PA conduit was associ-
ated with better distal left PA growth and more balanced
branch PA growth compared with the mBTS NP. The
Nakata index tended to be higher overall for group B patients
(202.9 vs 169.3 mm2/m2; P ¼.077) and was significantly
greater for the subset of group B patients who did not require
TABLE 1. Demographic, preoperative risk factors, and stage I
Norwood operative data
Group A: mBTS
NP (n ¼ 32)
Group B: RV–PA
NP (n ¼ 32) P value
Demographic data
Birth weight (kg) 3.11  0.44
(2.4–4)
2.96  0.6
(1.4–3.9)
.26
Male/female ratio 18:14 22:10 .439
Age at Norwood (d) 12.3  16.9
(1–79)
8.7  11.1 (1–49) .362
Aortic atresia
present*
21/32 (65.6%) 28/32 (87.5%) .077
Preoperative risk factors
Lowest pH 7.22  0.14
(6.69–7.38)
7.21  0.17
(6.67–7.39)
.827
Highest lactate
level (mg/dL)
57  66.3
(14–223)
60  57.5
(19–227)
.467
Stage I NP operative data
Bypass time (min) 43  18.9
(26–128)
36.8  8.7
(20–64)
.134
Crossclamp time
(min)
42  18.6
(30–69)
39.9  18.3
(22–53)
.874
DHCA time (min) 38.3  8.7
(5–52)
41.7  7.2 (29–55) .09
Shunt size (mm) 3.64  0.26
(3.0–4.5)
5.34  0.83 (4–8) <.001
Additional shunt
before Glenn*
1 (3.1%) 6 (18.8%) .02
Mean  standard deviation (range). *These data are expressed as total number of pa-
tients (% of primary study group). DHCA, Deep hypothermic circulatory arrest;
mBTS, modified Blalock–Taussig shunt; RV–PA, right ventricle–pulmonary artery
conduit; SD, standard deviation.rgery c June 2009
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Dan additional shunt (211.6 vs 169.3 mm2/m2; P ¼ .039).
This was mainly due to the larger left PA cross-sectional
area for group B patients (29 vs 19 mm2; P ¼ .001). The
improved left PA size resulted in more balanced branch
PA growth in the RV–PA conduit group with an observed
right PA/left PA ratio of 1.02 versus 1.39 in the mBTS group
(P ¼ .001). However, patients with an RV–PA conduit had
a greater reduction in central PA size than their counterparts
FIGURE 3. Kaplan–Meier reintervention curve for patients who under-
went stage I NP with either mBTS versus RV–PA. Starting point is the
day of stage I NP. No reinterventions occurred later than 6 months from
the time of stage I NP. A stratified actuarial table displays the number of pa-
tients at risk in each group (n) with 95% CI over 2-month intervals after
stage I NP. CI, Confidence interval; mBTS, modified Blalock–Taussig
shunt; mo, months; NP, Norwood procedure; RV–PA, right ventricle–pul-
monary artery conduit.with an mBTS (40.6% vs 60.2% mean reduction of central
PA cross-sectional area). Thus, 78.1% of RV–PA patients
met our criteria for central PA hypoplasia versus 43.8% of
mBTS patients (25/32 vs 14/32; P ¼ .01). Shunt stenosis
developed in 14 of 32 group B patients compared with
only 2 of 32 group A patients (P ¼ .001). Consequently,
in our primary study group, 6 patients with an RV–PA con-
duit required additional shunts during the intermediate stage
period versus only 1 additional shunt in mBTS patients (6/32
vs 1/32; P ¼ .02). No patients underwent catheter-based
interventions for alleviating RV–PA conduit or mBTS shunt
stenosis. The incidence of shunt-related PA stenosis was not
significantly different between the groups (group A 5/32 vs
group B 8/32; P ¼ .37), and both had similar frequency of
PA augmentation or repair at the time of the Glenn operation
(group A 8/32 vs group B 7/32; P ¼ .67). Kaplan–Meier
survival analysis was used to compare survival to Glenn
surgery with the competing risk factor of death (Figure 4).
We found a statistically significant improvement in survival
to Glenn for the RV–PA group (40/56, 71.4% survived) ver-
sus the mBTS group (55/103, 53.4% survived; P ¼ .042).
RV–PA NP patients underwent Glenn surgery significantly
earlier than mBTS NP patients (192 vs 246 days; P ¼ .028),
weighed significantly less (5.53 vs 6.55 kg; P ¼ .005), and
had lower arterial oxygen saturations at the time of Glenn
surgery (70% vs 75.5%; P ¼ .002).
DISCUSSION
Main Findings
The RV–PA modification to the NP has become widely
accepted as an effective alternative to the standard NPTABLE 2. Pre-Glenn cardiac catheterization data and stage II Glenn operative data
Group A: mBTS
NP (n ¼ 32)
Group B: All RV–PA
NP (n ¼ 32) P value
Sub-group B: RV–PA
NP only (n ¼ 26) P value
Cardiac catheterization data
Age at catheterization (d) 164.1  52.2 159.3  42.1 .682 149.4  38.0 .235
Qp/Qs ratio 1.47  0.92 1.22  0.63 .205 1.26  0.64 .633
RPA CSA (mm2) 30.8  16.9 28  11.9 .450 29  12.9 .851
LPA CSA (mm2) 19  9.9 29  13.4 .001 29.5  13.4 .001
Nakata index (mm2/m2) 169.3  78.2 202.9  70.6 .077 211.6  72.6 .039
RPA/LPA ratio 1.39  0.55 1.02  0.24 .001 1.02  0.22 .001
Shunt stenosis* 2 (6.25%) 14 (44%) .001 8 (31%) .032
Shunt-related PA stenosis* 5 (15.6%) 8 (25%) .374 7 (21.9%) .342
Central PA hypoplasia* 14 (43.8%) 25 (78.1%) .01 21 (80.8%) .009
Glenn operative data
Age at Glenn (d) 246  117.5 (121–681) 192  56.1 (94–334) .028 182.7  56.9 (94–334) .007
Weight at Glenn (kg) 6.55  1.53 (4.4–10.8) 5.53  1.03 (3.2–7.6) .005 5.37  0.95 (3.2–6.9) .002
Arterial O2 saturation (%) 75.5  8.6 (55–87) 70  7.7 (55–85) .002 71.5  6.5 (58–85) .03
Bypass time (min) 42.1  26.2 (15–83) 47.1  29.6 (13–93) .60 48.2  29.8 (13–90) .80
PA augmentation or repair* 8 (25%) 7 (26.9%) .667 7 (26.9%) .667
Mean standard deviation (range). *These data are expressed as total number of patients (% of primary study group). Subgroup B represents patients with RV–PA Norwood who
did not undergo an additional shunting procedure. Both group B and subgroup B are compared with group A for analysis. CSA, Cross-sectional area; LPA, left pulmonary artery;
mBTS, modified Blalock–Taussig shunt; PA, pulmonary artery; Qp/Qs, pulmonary/systemic flow rate; RPA, right pulmonary artery; RV–PA, right ventricle–pulmonary artery
conduit; SD, standard deviation.
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PA growth between the two surgical approaches as well as
shunt-related surgical outcomes. Our research revealed
that the NP with RV–PA conduit does result in significantly
larger distal left PA size and more evenly balanced branch
PA growth. However, there was a higher incidence of central
PA hypoplasia. Earlier studies have shown improved PA
growth in patients with an RV–PA conduit using a ratio of
combined branch PA diameter to descending aorta diame-
ter.7 Subsequent investigations confirmed a significantly
greater left PA index for RV–PA patients using echo-derived
measurements.8 More recently, Rumball and associates13
reported a 24% increase in the maximum indexed left PA
diameter of patients with RV–PA conduit NP versus the
mBTS NP using angiography. Similar to our study, they
also found the left PA to be significantly smaller in the
mBTS group. These results are consistent with Graham
and associates,20 who showed larger PA size for RV–PA
NP patients with a Nakata index of 270 versus 188 mm2/
m2 for mBTS patients (P ¼ .009). Our results were similar,
but they also revealed the finding of significant central PA
hypoplasia in the RV–PA group, which has not been widely
described for this patient population. We originally hypoth-
esized that the centralized PA insertion and more anatomi-
cally correct course of the RV–PA conduit would result in
improved PA growth. This theory was in part due to a previ-
ous study at our institution, which showed that a more
central insertion site for the mBTS to the main PA resulted
in more balanced branch PA growth.21 Additionally, we
FIGURE 4. Cumulative incidence curve for time to Glenn before death
(survival to Glenn with competing risk of death) for patients who underwent
stage I NP with either mBTS versus RV–PA. By 6 months, over 50% of
RV–PA NP patients had completed the Glenn versus only 20%
of mBTS NP patients. A stratified actuarial table displays the number of
patients at risk in each group (n) with 95% CI over 3-month intervals after
stage I NP. CI, Confidence interval; mBTS, modified Blalock–Taussig
shunt; mo, months; NP, Norwood procedure; RV–PA, right ventricle–pul-
monary artery conduit.1346 The Journal of Thoracic and Cardiovascular Susurmised that the increased pulsatility of RV–PA blood
flow would create improved expansion and recoil of the
PAs, promoting better distal growth. However, we did not
expect to find a higher incidence of central PA hypoplasia
in the RV–PA group. It is possible that the anteroposterior
course of the conduit may place tension on the branch PAs
over time, causing them to narrow. Another possibility is
compression from the neoaortic arch on the central PA,
but this should occur equally in both groups. It is unclear
what the long-term ramifications of such central PA hypo-
plasia will be for the RV–PA NP patients.
Surgical Implications
One can speculate that the smaller left PA size in the
mBTS group or the higher incidence of central PA hypopla-
sia in the RV–PA group might lead to an increased need for
PA augmentation during the Glenn operation for either
group. In a recent report by Griselli and associates,18 the
need to address central PA stenosis and PA hypoplasia
was much higher in their RV–PA NP patients, 28% versus
98%. However, in that study, PA augmentation was per-
formed almost exclusively as part of the standard Glenn pro-
cedure, which is not the case at our institution. In our study
population, additional PA surgical intervention was per-
formed only as deemed necessary by the surgeon, which re-
sulted in similar rates of PA augmentation for the 2 groups at
the Glenn procedure. This was possibly due to the absence of
a discrete or localized segmental stenosis that could ade-
quately be addressed with surgical patch angioplasty. Both
groups showed no major differences in outcomes on the ba-
sis of their PA growth by the Glenn surgery. However, dif-
ferences in PA growth may affect long-term outcomes for
these patients rather than short-term outcomes such as differ-
ences in oxygenation. This study was designed to investigate
up to the Glenn stage, inasmuch as the mid to long-term out-
comes related to PA growth are not yet known. Previous
studies have suggested the RV–PA conduit provides more
stable postoperative physiology resulting in lower postoper-
ative mortality and improved early outcomes.9-12 Our sur-
vival analysis from stage I NP to Glenn for both groups
with the competing risk of death showed a significant im-
provement in survival for the RV–PA NP patients (40/56
vs 55/103 survived to Glenn; P ¼ .042). This may be par-
tially attributed to a learning curve for the NP as well as im-
provements in postoperative care from the earlier era of the
mBTS to the more current era of the RV–PA conduit. It also
may be skewed by the fact that the time between intermedi-
ate stages was significantly shorter in group B because the
patients receiving RV–PA conduits often required earlier
Glenn surgery than is customary at our institution or an ad-
ditional shunt procedure (mBTS) before the Glenn operation
because of worsening cyanosis. The RV–PA conduit had
a tendency to obstruct, particularly at the proximal insertion
site of the conduit into the RV infundibulum. This appearedrgery c June 2009
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the conduit. As a result, the RV–PA NP patients went for
Glenn surgery almost 2 months earlier and weighed on aver-
age 1 kg less than their counterparts with mBTS NP. The
premature Glenn operation in RV–PA NP patients has
been previously reported, but the RV–PA conduit patients
in that study showed better weight gain.22 To deal with
this problem of early conduit obstruction, our surgeon mod-
ified his technique for RV–PA conduit placement by coring
out a small portion of the RV wall at the RV–PA insertion
site (instead of a simple ventriculotomy) as well as more ag-
gressive muscular RV infundibular resection just below the
insertion site.
Clinical Implications
Our results suggest that patients after the RV–PA NP
should be monitored more closely with frequent pulse
oximetry checks to detect worsening cyanosis as a result
of progressive conduit stenosis. A recent study showed
that a home monitoring program for patients with HLHS
that included daily weight and pulse oximetry checks could
significantly reduced intermediate stage mortality after stage
I NP.23 The RV–PA NP patients had better distal left PA
growth and more balanced branch PA growth when com-
pared with the mBTS NP patients, which may increase the
success rate for the Fontan procedure and decrease the
need for either surgical or catheter-based intervention to
augment or stent narrowed PAs.24,25 However, this remains
to be seen for these patients inasmuch as it is still unclear
what impact their greater degree of central PA hypoplasia
will have on the next stage of surgery. Although the ade-
quacy of PA size is still somewhat controversial, it has
been shown that a subset group of Fontan patients with small
PAs have worse outcomes.26 Differences in the need for sur-
gical and/or catheter-based intervention between these
groups will likely become more evident after the Glenn
operation. Our follow-up study will look specifically at the
outcomes and clinical course for these patients through the
early postoperative Fontan stage with a focus on surgical
reintervention and catheter-based reintervention on the
PAs. We hope the results of this follow-up study will further
elucidate the impact of differential PA growth in these two
surgical populations.
Study Limitations
The retrospective nature of this study limited our ability to
control for patient selection bias and required the use of
a historical control group for which we could not eliminate
confounding variables. A significant number of patients
had their cardiac catheterizations performed at outside insti-
tutions, which prevented inclusion in this study. It is possible
that exclusion of these patients may have altered some of our
results. The RV–PA group included 6 patients who received
an additional shunt before the pre-Glenn catheterization thatThe Journal of Thoracic and Cmay have altered PA growth and skewed our measurements.
However, subgroup analysis of the RV–PA patients without
an additional shunt supported the overall findings. Angio-
graphic analysis of the PAs was very challenging in this
study population owing to high variability of PA structure
and lack of uniformity of the angiographic data. The ongo-
ing randomized, multicenter single ventricle reconstruction
trial ideally will resolve many of these questions and avoid
many of the limitations associated with retrospective studies.
CONCLUSIONS
The RV–PA NP promotes greater distal left PA growth,
resulting in more balanced distal branch PA size in infants
with HLHS by the time of the Glenn operation. However,
it is also associated with a greater degree of central PA
hypoplasia as well as a higher incidence of shunt stenosis
that often results in earlier timing of Glenn surgery or addi-
tional shunt placement during the first intermediate stage
owing to progressive cyanosis.
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